Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Keratolysis
Interventions: Riboflavin, Dextran, UVA Light Source; Drug · Device
Lead sponsor: Joseph B. Ciolino, MD; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 13
States / cities: Los Angeles, California • Sacramento, California • San Diego, California + 10 more

Conditions: Prepubertal Labial Adhesions
Interventions: Estradiol cream 0.01%, Cetaphil; Drug
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 3 Months to 12 Years · Female only
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Prostate Cancer (Diagnosis)
Interventions: HeLP TM; Device
Lead sponsor: Duke University; Other
Eligibility: 40 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Rhizomelic Chondrodysplasia Punctata
Interventions: Not listed
Lead sponsor: MED-LIFE DISCOVERIES LP; Industry
Eligibility: 6 Months to 21 Years
Enrollment: 75 participants
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Degenerative Disc Disease, Scoliosis
Interventions: Oblique Lateral Interbody Fusion; Procedure
Lead sponsor: Medtronic Spinal and Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 6
States / cities: Murrieta, California • San Francisco, California • Melbourne, Florida + 3 more

Conditions: Obstructive Sleep Apnea of Child
Interventions: Adenotonsillectomy, Drug-induced sleep endoscopy directed surgery; Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 2 Years to 18 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cataract, Presbyopia
Interventions: Neutral Aspheric Monofocal IOL, Negative Aspheric Monofocal IOL; Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 95 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Obesity & Overweight, Weight Loss, Preventative Health, Body Weight, Cardiovascular Disease Risk Factor
Interventions: Noom Weight, Free Tier, Education-only control, Semaglutide, Tirzepatide, Microdose semaglutide, Microdose tirzepatide; Behavioral · Drug
Lead sponsor: Noom Inc.; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 2,310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Cardiac Arrhythmia
Interventions: KODEX-EPD system; Device
Lead sponsor: EPD Solutions, A Philips Company; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Staten Island, New York

Conditions: Stroke, Ischemic, Stroke Hemorrhagic, Spastic Hemiparesis
Interventions: Contralateral C7 root transfer for the treatment of spastic hemiparesis.; Procedure
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Knee Osteoarthristis, Total Knee Anthroplasty
Interventions: Total Knee Arthroplasty; Device
Lead sponsor: Maxx Orthopedics Inc; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Leawood, Kansas • San Antonio, Texas

Conditions: Lumbar Central Canal Stenoses, Neural Foraminal Stenoses
Interventions: Upright CT; Radiation
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Skin Laxity (Submental and Neck), Facial Skin Laxity, Submental Tissue Laxity
Interventions: ULTRAFORMER MPT PLUS, Ulthera System; Device
Lead sponsor: CLASSYS Inc.; Industry
Eligibility: 30 Years to 65 Years
Enrollment: 273 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Los Angeles, California • Charlotte, North Carolina • Wilmington, North Carolina + 2 more

Conditions: Hip Osteoarthritis
Interventions: Lumbar plexus block, Quadratus lumborum type 3 block, Ropivacaine injection; Procedure · Drug
Lead sponsor: Sharad Khetarpal; Other
Eligibility: 18 Years to 90 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Cardiac Surgery, Sternotomy
Interventions: ESP block, PIF block, Ultrasound, Bupivacain; Procedure · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 85 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Wounds, Compartment Syndromes
Interventions: Wound Care -Wound Vacuum Assisted Closure (VAC), Wound Care - Wet to Dry Dressing Changes; Device · Procedure
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Ulcerative Colitis
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 80 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Hereditary Spastic Paraplegia Type 50
Interventions: MELPIDA; Genetic
Lead sponsor: Elpida Therapeutics SPC; Industry
Eligibility: 4 Months to 72 Months
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF), Biallelic Mutations in the Gap Junction Beta 2 (GJB2) Gene, Digenic Mutations in GJB2/Gap Junction Beta 6 (GJB6) Genes
Interventions: Not listed
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: Up to 7 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Phoenix, Arizona • Columbus, Ohio

Conditions: Renal Disease, Kidney Failure
Interventions: vascular access graft implantation; Device
Lead sponsor: Maquet Cardiovascular; Industry
Eligibility: 18 Years and older
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 8
States / cities: Long Beach, California • Atlanta, Georgia • Chicago, Illinois + 5 more

Conditions: Asthma
Interventions: Not listed
Lead sponsor: Chiesi Farmaceutici S.p.A.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 872 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 4
States / cities: Denver, Colorado • Durham, North Carolina • Cleveland, Ohio + 1 more

Conditions: Femoracetabular Impingement, Pain, Postoperative
Interventions: Morphine with clonidine, Normal saline; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: To Collect Information About Visual Outcomes and Participant Satisfaction
Interventions: Tecnis one-piece MF IOL, Crystalens AO; Device
Lead sponsor: Innovative Medical; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Lake Villa, Illinois

Conditions: Fluoroscopy for Spine Surgery
Interventions: LessRay, Standard Fluoroscopy; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit

Treatment of Prepubertal Labial Adhesions

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

RCDP Natural History Study

OLIF25™ /OLIF51™ Study

Surgical Treatment of Children With OSA and Small Tonsils or Down Syndrome

MULTICENTER, DOUBLE-ARM, PATIENT AND ASSESSOR-MASKED, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL TO COMPARE VISUAL PERFORMANCE OF NEGATIVE AND NEUTRAL ASPHERIC MONOFOCAL INTRAOCULAR LENSES

GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study

Prospective Procedural Data Collection for Continuous Improvement of the KODEX - EPD™ System Performance.

Utility of CC7 Transfer in Stroke Subtypes

Prospective, In-Vivo, Post-Market Safety and Efficacy Surveillance Registry of the MAXX Orthopedics, Freedom Total Knee® System

Prospective Evaluation of Upright Versus Supine CT Myelography of the Lumbar Spine

Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement

ESP/PIF for Sternotomy

Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes

Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study

Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.

A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

The Boston Scientific ACCESS Trial

AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)

Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy

Prospective Evaluation of Visual Outcomes With Tecnis One-Piece Multifocal Intraocular Lenses Compared With Patients Previously Implanted With Crystalens Aspheric Optic (AO)

A Prospective Study of LessRay Enhanced Versus Standard Fluoroscopic Visualization in Surgical Placement of Spinal Cord Stimulator